Microbot Medical Analyst Ratings
Microbot Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/18/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/26/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/06/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 05/09/2023 | 429.8% | HC Wainwright & Co. | $20 → $8 | Maintains | Buy |
| 08/18/2020 | 1224.5% | HC Wainwright & Co. | $19 → $20 | Maintains | Buy |
| 01/13/2020 | 1621.85% | HC Wainwright & Co. | $12 → $26 | Reiterates | → Buy |
| 12/24/2019 | 694.7% | HC Wainwright & Co. | $10 → $12 | Reiterates | → Buy |
| 07/22/2019 | 562.25% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 11/19/2018 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2023 年 10 月 18 日 | 429.8% | HC Wainwright & Co. | → 8 美元 | 重申 | 购买 → 购买 |
| 06/26/2023 | 429.8% | HC Wainwright & Co. | → 8 美元 | 重申 | 购买 → 购买 |
| 06/06/2023 | 429.8% | HC Wainwright & Co. | → 8 美元 | 重申 | → 购买 |
| 05/09/2023 | 429.8% | HC Wainwright & Co. | 20 美元 → 8 美元 | 维护 | 买 |
| 08/18/2020 | 1224.5% | HC Wainwright & Co. | 19 美元 → 20 美元 | 维护 | 买 |
| 2020 年 1 月 13 日 | 1621.85% | HC Wainwright & Co. | 12 美元 → 26 美元 | 重申 | → 购买 |
| 2019 年 12 月 24 日 | 694.7% | HC Wainwright & Co. | 10 美元 → 12 美元 | 重申 | → 购买 |
| 07/22/2019 | 562.25% | HC Wainwright & Co. | → 10 美元 | 启动覆盖范围开启 | → 购买 |
| 11/19/2018 | — | 拉登堡塔尔曼 | 降级 | 买入 → 中性 |
What is the target price for Microbot Medical (MBOT)?
Microbot Medical（MBOT）的目标价格是多少？
The latest price target for Microbot Medical (NASDAQ: MBOT) was reported by HC Wainwright & Co. on October 18, 2023. The analyst firm set a price target for $8.00 expecting MBOT to rise to within 12 months (a possible 429.80% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年10月18日公布了Microbot Medical（纳斯达克股票代码：MBOT）的最新目标股价。该分析公司将目标股价定为8.00美元，预计MBOT将在12个月内上涨至429.80％（可能上涨429.80％）。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Microbot Medical (MBOT)?
Microbot Medical（MBOT）的最新分析师评级是多少？
The latest analyst rating for Microbot Medical (NASDAQ: MBOT) was provided by HC Wainwright & Co., and Microbot Medical reiterated their buy rating.
Microbot Medical（纳斯达克股票代码：MBOT）的最新分析师评级由HC Wainwright & Co. 提供，Microbot Medical重申了买入评级。
When is the next analyst rating going to be posted or updated for Microbot Medical (MBOT)?
Microbot Medical（MBOT）的下一次分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Microbot Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Microbot Medical was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.
分析师在进行了广泛的研究后得出了股票评级，包括阅读公开财务报表、与Microbot Medical的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Microbot Medical的最后一次评级是在2023年10月18日提交的，因此你应该预计下一个评级将在2024年10月18日左右公布。
Is the Analyst Rating Microbot Medical (MBOT) correct?
分析师对Microbot Medical (MBOT) 的评级是否正确？
While ratings are subjective and will change, the latest Microbot Medical (MBOT) rating was a reiterated with a price target of $0.00 to $8.00. The current price Microbot Medical (MBOT) is trading at is $1.51, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但重申了最新的Microbot Medical（MBOT）评级，目标股价为0.00美元至8.00美元。Microbot Medical（MBOT）目前的交易价格为1.51美元，在分析师的预测区间内。